Sign Up
OverviewAPI
Novo Nordisk is preparing for the launch of a weight-loss pill, but faces challenges in widespread distribution due to the potential impact on its existing best-sellers. The company is leading the obesity drugs battle with its massive deal, but also faces scrutiny from food CEOs and the weakening of the Danish krone.

Ask a question